kabutan

Fuso Pharma, Ordinary Profit Unexpectedly Turn to Loss for Last Fiscal Year, 40% Decrease in The Current Fiscal Year

Tue May 12, 2026 3:30 pm JST Earnings

4538 Fuso Pharmaceutical Industries,Ltd. 【J-GAAP】

Earnings Report

Fuso Pharmaceutical Industries,Ltd. <4538> [TSE Prime] announced its financial results after the market closed on May 12th (15:30). The ordinary profit (non-consolidated) for the fiscal year ended March 2026 decreased by 37.9% from the previous period to 2.34 billion yen, falling below the forecast of 3.30 billion yen. For the fiscal year ending March 2027, the ordinary profit is expected to drop by 40.4% from the previous period to 1.40 billion yen.

In the most recent three-month period, from January to March (4Q), the ordinary profit significantly dropped to 0.13 billion yen, a 69.7% decrease compared to the same period last year. The operating profit margin worsened from 3.6% in the same period last year to 1.9%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 55,407 1,964 1,868 1,377 160.0 70 May 10, 2024 J-GAAP
Mar, 2025 60,563 4,131 3,780 -3,288 -385.0 82 May 9, 2025 J-GAAP
Mar, 2026 62,307 2,639 2,349 2,011 235.6 90 May 12, 2026 J-GAAP
YoY +2.9% -36.1% -37.9% － －

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance 61,500 3,400 3,300 2,300 269.4 90 May 9, 2025 J-GAAP
Mar, 2026 Results 62,307 2,639 2,349 2,011 235.6 90 May 12, 2026 J-GAAP
Revision Rate +1.3% -22.4% -28.8% -12.6% -12.5%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 31,229 1,247 1,131 831 97.4 45 Nov 10, 2025 J-GAAP
Apr - Sep, 2026 Guidance 31,500 800 600 500 58.6 45 May 12, 2026 J-GAAP
YoY +0.9% -35.8% -46.9% -39.8% -39.9%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 60,563 4,131 3,780 -3,288 -385.0 82 May 9, 2025 J-GAAP
Mar, 2026 62,307 2,639 2,349 2,011 235.6 90 May 12, 2026 J-GAAP
Mar, 2027 Guidance 63,200 2,000 1,400 1,300 152.3 90 May 12, 2026 J-GAAP
YoY +1.4% -24.2% -40.4% -35.4% -35.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 13,904 498 439 -5,690 -666.2 3.6 May 9, 2025 J-GAAP
Apr - Jun, 2025 15,503 596 647 462 54.1 3.8 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 15,726 651 484 369 43.3 4.1 Nov 10, 2025 J-GAAP
Oct - Dec, 2025 17,036 1,120 1,085 853 99.9 6.6 Feb 12, 2026 J-GAAP
Jan - Mar, 2026 14,042 272 133 327 38.3 1.9 May 12, 2026 J-GAAP
YoY +1.0% -45.4% -69.7% － －

Related Articles